The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Large Is The Continuous Renal Replacement Therapy Market Projected To Become By 2030 Based On Its 2026 Valuation?
The continuous renal replacement therapy market size has seen rapid growth in recent years. It is forecast to grow from $1.73 billion in 2025 to $1.92 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.8%. Historically, this expansion can be attributed to a rising incidence of acute kidney injury in critical care, increasing ICU admissions for sepsis and multi-organ failure, the growing use of renal support therapies, expansion of critical care infrastructure, and improved survival of critically ill patients.
The continuous renal replacement therapy market size is anticipated to undergo significant expansion over the next few years. It is forecast to grow to $2.77 billion in 2030, achieving a compound annual growth rate (CAGR) of 9.6%. The expansion expected during this period can be attributed to an aging population facing a higher risk of acute kidney injury, the increasing prevalence of critical illnesses, a wider adoption of advanced renal support technologies, a growing emphasis on individualized critical care treatment, and the expanding intensive care capacity in emerging markets. Noteworthy trends in the forecast period include the increasing integration of CRRT in intensive care units, a greater utilization of continuous therapies for hemodynamically unstable patients, a rising demand for precise fluid and electrolyte management, the broader application of CRRT in pediatric and neonatal care, and an increasing preference for integrated CRRT systems and their associated consumables.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15777&type=smp
Which Market Drivers Are Supporting The Expansion Of The Continuous Renal Replacement Therapy Market?
The increasing occurrence of chronic kidney diseases is expected to propel the growth of the continuous renal replacement therapy market. Chronic kidney disease (CKD) is a long-term condition where the kidneys progressively lose function over time, leading to impaired filtration of waste products from the blood. The rising incidence of chronic kidney diseases is influenced by lifestyle changes, aging populations, and increasing rates of diabetes and hypertension. Continuous renal replacement therapy is utilized in chronic kidney disease for acute exacerbations or complications to manage fluid balance and continuously remove metabolic waste products. For instance, in May 2024, according to the Centers for Disease Control and Prevention, a U.S.-based national public health agency, more than 1 in 7 adults in the US, over 35.5 million people, are estimated to have chronic kidney disease (CKD). Notably, nearly 90% of these individuals remain unaware of their condition, underscoring a significant gap in early detection and awareness efforts for CKD in the US. Therefore, the increasing incidence of chronic kidney diseases is driving the growth of the continuous renal replacement therapy market.
What Segment Groups Are Identified Within The Continuous Renal Replacement Therapy Market?
The continuous renal replacement therapy market covered in this report is segmented –
1) By Product: System, Consumables
2) By Therapy: Renal, Non-Renal
3) By Modality: Slow Continuous Ultra-Filtration (SCUF), Continuous Venovenous Hemofiltration (CVVH), Continuous Venovenous Hemodialysis (CVVHD), Continuous Venovenous Hemodiafiltration (CVVHDF)
4) By Age Group: Adults, Pediatrics Or Neonates
5) By End-Users: Hospitals, Ambulatory Care
Subsegments:
1) By System: Hemofilters, CRRT Machines, Blood Tubing Sets
2) By Consumables: Dialysate Solutions, Replacement Fluids, Catheters, Bloodline Sets
What Trends Are Advancing Progress In The Continuous Renal Replacement Therapy Market?
Major companies within the continuous renal replacement therapy market are concentrating on developing advanced renal therapy options for dialysis patients, aiming to boost treatment effectiveness, better patient outcomes, and lessen issues linked with conventional dialysis techniques. This advanced treatment functions without interruption, typically spanning 24 hours, and exerts less strain on the body compared to standard dialysis, rendering it appropriate for individuals suffering from acute kidney injuries or severe medical conditions. For instance, in January 2023, a report from Peconic Bay Medical Center (PBMC), a US medical facility providing emergency and surgical services, highlighted the introduction of a novel renal therapy alternative for dialysis patients. This therapy is intended to offer greater comfort to patients whose medical circumstances prevent them from enduring standard dialysis. CRRT is delivered at a reduced pace compared to traditional dialysis, which aids in reducing the burden on critically ill patients.
Which Companies Hold Significant Positions In The Continuous Renal Replacement Therapy Market?
Major companies operating in the continuous renal replacement therapy market are Medtronic Plc, Fresenius Medical Care AG & Co. KGaA, Asahi Kasei Corporation, Toray Industries Inc., Baxter International Inc., B. Braun Melsungen AG, Terumo Corporation, Nipro Corporation, NxStage Medical Inc., Gambro AB, JMS Co. Ltd., Quanta Dialysis Technologies Ltd., Bellco S.r.l., Ningbo Tianyi Medical Devices Co. Ltd., Kawasumi Laboratories Inc., Medica S.p.A., Infomed SA, Nikkiso Co. Ltd., Anjue Medical Equipment Co. Ltd., Toray Medical Co. Ltd., Kawasumi Hemofiltration Inc.
Read the full continuous renal replacement therapy market report here:
How Is The Continuous Renal Replacement Therapy Market Distributed Across Key Geographic Regions?
North America was the largest region in the continuous renal replacement therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the continuous renal replacement therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Continuous Renal Replacement Therapy Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=15777&type=smp
Browse Through More Reports Similar to the Global Continuous Renal Replacement Therapy Market 2026, By The Business Research Company
Respiratory Inhaler Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/respiratory-inhaler-devices-global-market-report
Air Pressure Sensors Market Report 2026
https://www.thebusinessresearchcompany.com/report/air-pressure-sensors-global-market-report
Respiratory Oxygen Delivery Devices Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model